Professor, Medicine and Pathology, Pennsylvania State University College of Medicine
Hematology
Dr. Witold B. Rybka, MD
|
|
Give Review
Witold Rybka practices Hematology. Witold B. Rybka, MD is also published. He has 59 publications published. The lastest publication: "Tetraploidy in acute myeloid leukemia secondary to large cell lymphoma.' He accepts Medicare.
Publications
- Unusual Case of Recurrent Extraneural Metastatic Medulloblastoma in a Young Adult: Durable Complete Remission With Ewing Sarcoma Chemotherapy Regimen and Consolidation...
- G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete enGraftment after allogeneic hematopoietic transplantation.
- Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic Cells for autologous transplantation.
- Durable response to combination therapy including staphylococcal protein A immunoadsorption in life-threatening refractory autoimmune hemolysis.
- Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man.
- Sirolimus in unmanipulated haploidentical Cell transplantation.
- Tetraploidy in Acute myeloid leukemia secondary to large cell lymphoma.
- Autologous peripheral blood stem Cell transplantation and adoptive immunotherapy with activated natural killer Cells in the immediate posttransplant period.
- Allogeneic peripheral blood stem Cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years.
- Spontaneous gingival bleeding in an otherwise asymptomatic patient.
- The use of CT densitometry to predict Lung toxicity in bone marrow transplant patients.
- Thrombotic Thrombocytopenic purpura: the Montreal General Hospital's experience from 1985 to 1988.
- Reducing parenteral energy and protein intake improves metabolic homeostasis after bone marrow transplantation.
- Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
- Ablative therapy in bone marrow transplantation.
- A comparison of clinical criteria for the diagnosis of veno-occlusive Disease of the liver after bone marrow transplantation.
- Enhancement of the immunosuppressive effect of Graft-versus-host disease by partial-body irradiation.
- Interstitial pneumonitis following total body irradiation for bone marrow transplantation using two different dose rates.
- Dose rate dependence of response of mouse Lung to irradiation.
- Amplification of the Graft-versus-host reaction by partial body irradiation.
- Intravenous immunoglobulin therapy for refractory Chronic idiopathic thrombocytopenic purpura.
- Radiation response of haematopoietic Cell lines of human origin.
- Late Graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6.
- A unique population of CD34+ Cells in cord blood.
- Enumeration of CD34+ hematopoietic stem Cells for reconstitution following myeloablative therapy.
- Viability of human marrow after long-term cryopreservation.
- [The treatment of Acute leukemia with bone marrow transplantation: Quebec experience].
- Hematopoietic progenitor Cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation.
- Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients.
- Autologous bone marrow transplantation for adult Acute leukemia.
- Amplification of the Graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration.
- Reversal of Graft-versus-host disease with infusion of autologous bone marrow.
- Simultaneous solid organ, bone marrow, and islet allotransplantation in type I diabetic patients.
- Human bone marrow obtained from vertebral bodies: Cell isolation, phenotyping, progenitor assay, and transplantation.
- Human-to-baboon bone marrow transplantation after conditioning with nonlethal irradiation.
- Xenotransplantation of hematopoietic Cells resistant to HIV as a potential treatment for patients with AIDS.
- Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies.
- Human herpesvirus 6: infection and Disease following autologous and allogeneic bone marrow transplantation.
- High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast Cancer.
- Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow Cells.
- Relationship of CD34+ Cell dose to early and late hematopoiesis following autologous peripheral blood stem Cell transplantation.
- Augmentation of natural chimerism with donor bone marrow in orthotopic Liver recipients.
- Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism.
- Pure red Cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
- Bone marrow augmentation of donor-Cell chimerism in kidney, liver, heart, and pancreas islet transplantation.
- Graft failure after an umbilical cord blood transplant in a patient with severe aplastic Anemia.
- FK 506 interaction with danazol.
- [Bone marrow transplantation in bone marrow aplasias].
- Graft-v-host disease is associated with autoimmune-like thrombocytopenia.
- Factors influencing mobilization and engraftment in patients with metastatic breast Cancer undergoing PBSC transplantation.
- Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with Lymphoma.
- High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast Cancer.
- High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast Cancer: hematopoieti...
- The use of counterflow centrifugal elutriation for the depletion of T Cells from unrelated donor bone marrow.
- BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma.
- Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast Cancer.
- Bone marrow contributes to epithelial Cancers in mice and humans as developmental mimicry.
- Control of advanced and refractory Acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Toronto Faculty of Medicine
Hospital
-
Penn State Milton S. Hershey Medical Center
Drug Facts
| NPI NUMBER | 1881643047 | |
| NPPES Provider LastName | RYBKA | |
| NPPES Provider FirstName | WITOLD | |
| NPPES Provider ZIPCode | 170332360 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 360.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 3.06 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1881643047 |
| Last Name Of The Provider | RYBKA |
| First Name Of The Provider | WITOLD |
| View All |
Similar Doctors
|
|
Dr. Marc A. Rovito, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leah Cream, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond J. Hohl, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hamid A. Al-Mondhiry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aman Garsa, MD |
|
|
Dr. Juanita Evans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James O. Ballard, MD |
|
|
Dr. Sheldon Holder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bora Lim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa R. George, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Evans, MD |
|
|
Dr. Mithun V. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Jenkins, MD |
|
|
Susan A. Rokita, CRNP
This Doctor is OpenDoctor Recommended.
|